Our data indicate that dapagliflozin attenuates right ventricular systolic pressure, right ventricular hypertrophy, and pulmonary vascular remodeling and decreases NLRP3 inflammasome activation in MCT-induced PAH rats. This evidence concerns the gene NLRP3 and pulmonary arterial hypertension.